- Home
- NRK vs AMLX Comparison
NRK vs AMLX Comparison
Compare NRK & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRK
- AMLX
- Stock Information
- Founded
- NRK 2002
- AMLX 2014
- Country
- NRK United States
- AMLX United States
- Employees
- NRK N/A
- AMLX N/A
- Industry
- NRK Trusts Except Educational Religious and Charitable
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- NRK Finance
- AMLX Health Care
- Exchange
- NRK Nasdaq
- AMLX Nasdaq
- Market Cap
- NRK 824.4M
- AMLX 749.9M
- IPO Year
- NRK N/A
- AMLX 2022
- Fundamental
- Price
- NRK $9.96
- AMLX $11.85
- Analyst Decision
- NRK
- AMLX Strong Buy
- Analyst Count
- NRK 0
- AMLX 7
- Target Price
- NRK N/A
- AMLX $13.43
- AVG Volume (30 Days)
- NRK 187.3K
- AMLX 1.9M
- Earning Date
- NRK 01-01-0001
- AMLX 11-06-2025
- Dividend Yield
- NRK 4.10%
- AMLX N/A
- EPS Growth
- NRK N/A
- AMLX N/A
- EPS
- NRK N/A
- AMLX N/A
- Revenue
- NRK N/A
- AMLX N/A
- Revenue This Year
- NRK N/A
- AMLX N/A
- Revenue Next Year
- NRK N/A
- AMLX N/A
- P/E Ratio
- NRK N/A
- AMLX N/A
- Revenue Growth
- NRK N/A
- AMLX N/A
- 52 Week Low
- NRK $8.95
- AMLX $2.59
- 52 Week High
- NRK $11.09
- AMLX $12.25
- Technical
- Relative Strength Index (RSI)
- NRK 76.22
- AMLX 77.55
- Support Level
- NRK $9.45
- AMLX $9.15
- Resistance Level
- NRK $10.00
- AMLX $12.25
- Average True Range (ATR)
- NRK 0.07
- AMLX 0.57
- MACD
- NRK 0.06
- AMLX 0.20
- Stochastic Oscillator
- NRK 93.22
- AMLX 89.39
About NRK Nuveen New York AMT-Free Quality Municipal Income Fund
Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. Its investment objective is to provide current income exempt from regular federal, New York State, and New York City income taxes and from the federal alternative minimum tax applies to individuals and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.